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- General Experimental Procedures. All reactions were performed in glassware under a positive pressure of argon. The normal-phase flash column chromatography was performed as described by Still (Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978 , 43, 2923 -2925 , employing EMD silica gel 60 (230-400 mesh ASTM). TLC analyses were performed on EMD 250 μm Silica Gel 60 F 254 plates and visualized by quenching of UV fluorescence (λ max = 254 nm), or by staining ceric ammonium molybdate. 1 H and 13 C NMR spectra were recorded on Varian Inova-600, Inova-500, or Inova-400. Chemical shifts for 1 H and 13 C NMR spectra are reported in ppm (δ) relative to the 1 H and 13 C signals in the solvent (CDCl3: δ 7.26, 77.16 ppm; methanol-d4: δ 3.31, 49.00 ppm) and the multiplicities are presented as follows: s = singlet, d = doublet, t = triplet, m = multiplet. Mass spectra were acquired on Agilent 6120 Single Quadrupole LC/MS. Preparative HPLC was performed using a Waters Atlantis dC18 OBD 5 μm column with dimension 19×150 mm or Eclipse XDB-C18 5 μm column with dimension 9.4×250 mm. The CD spectrum was recorded on an Aviv model 62DS spectropolarimeter in water at 25 °C. Aldehyde 6. To a solution of N-(benzyloxymethyl)imidazole 5 (1.59 g, 8.45 mmol, 1.0 equiv) in anhydrous tetrahydrofuran (100 mL) at -78 °C was added n-butyllithium (5.80 mL, 9.28 mmol, 1.1 equiv, 1.6 M in hexanes) dropwisely. After stirring at -78 °C for 1 h, a solution of N-chlorosuccinimide (1.38 g, 10.3 mmol, 1.2 equiv) in tetrahydrofuran (50 mL) was transferred into the reaction through a stainless steel cannula over 10 min. After stirring at -78 °C for 1 h, n-butyllithium (15.8 mL, 25.3 mmol, 3.0 equiv, 1.6 M in hexanes) was slowly added to the reaction mixture at the same temperature, and the reaction was stirred for another 1 h. Then N,N-dimethylformamide (3.27 mL, 42.2 mmol, 5.0 equiv) was added slowly at -78 °C and the reaction was stirred for 1 h before quenched with an aqueous solution of sodium dihyrdogen phosphate (35 mL, 2.0 M). The solvents were then removed by rotary evaporator and the residue was partitioned between ethyl acetate (200 mL) and brine (100 mL). The organic layer was further washed with brine (100 mL×3), dried over sodium sulfate, filtered and concentrated. The product 6 was obtained as colorless crystals (1.18 g, 56% yield) after recrystallizing from ethyl acetate and hexanes. R f = 0.33 (50% ethyl acetate-hexanes); 1 H NMR (400 MHz, CDCl 3 ) δ 9.65 (s, 1H), 7.66 (s, 1H), 7.44-7.18 (m, 5H), 5.83 (s, 2H), 4.62 (s, 2H); 13 C NMR (125 MHz, CDCl 3 ) δ 178. 4, 142.4, 141.6, 136.6, 132.3, 128.5, 128.1, 127.5, 74.1, 71.4 Azide 7. To a solution of aldehyde 6 (1.02 g, 4.07 mmol, 1.0 equiv) in anhydrous N,N-dimethylformamide (10 mL) was added sodium azide (0.397 g, 6.10 mmol, 1.5 equiv) at 23 °C. The reaction was heated to 50 °C for 16 h. Then the reaction was diluted with ethyl acetate (200 mL) and washed with brine (100 mL×5), dried over sodium sulfate, filtered, concentrated, and dried under high vacuum at 50 °C for 1 h. The crude product 7 was obtained as dark red oil (0.962 g, 92% crude yield), which was directly used for the next step without purification. R f = 0.45 (50% ethyl acetate-hexanes); 1 H NMR (400 MHz, CDCl 3 ) δ 9.60 (s, 1H), 7.60 (s, 1H), 7.39-7.21 (m, 5H), 5.61 (s, 2H), 4.60 (s, 2H); 13 C NMR (100 MHz, CDCl 3 ) δ 178. 3, 148.7, 142.7, 136.9, 130.6, 128.5, 128.1, 127.7, 73.0, 71.6 Ester 9. To a solution of allylic alcohol 8 (0.525 g, 2.04 mmol, 1.0 equiv) and Boc-β-alanine (0.405 g, 2.14 mmol, 1.05 equiv) in anhydrous methylene chloride (20 mL) were added N,N'-dicyclohexylcarbodiimide (0.442 g, 2.14 mmol, 1.05 equiv) and 4-dimethylaminopyridine (12 mg, 0.10 mmol, 0.05 equiv) at 23 °C. After stirring for 2 h, the solvent was removed. The residue was dissolved in several drops of methylene chloride, and then N,N'-dicyclohexylurea was crushed out with hexanes (40 mL). The suspension was filtered, dried over sodium sulfate, filtered again and concentrated to give the ester 9 as colorless oil. The crude was used directly for the next step without purification. R f = 0.68 (50% ethyl acetate-hexanes); MS(ESI) + c + β-Ketoester 10. To a solution of crude ester 9 (0.90 g, 2.04 mmol, 1.0 equiv) in anhydrous tetrahydrofuran (10 mL) at -78 °C was added lithium bis(trimethylsilyl)amide (5.10 mL, 5.10 mmol, 2.5 equiv, 1.0 M in tetrahydrofuran) dropwisely. After stirring at -78 °C for 1 h, a solution of aldehyde 7 (0.578 g, 2.24 mmol, 1.1 equiv) in tetrahydrofuran (10 mL) was added through a stainless steel cannula over 10 min. The reaction was stirred at -78 °C for 2.5 h before quenched with an acetic acid solution in tetrahydrofuran (2.0 mL, 1:4 v/v). The solvent was then removed by rotary evaporator. The residue was dissolved in ethyl acetate (100 mL), washed with brine (50 mL×2), dried over sodium sulfate, filtered and concentrated to afford the aldol product as pale yellow oil. This oil was dissolved in anhydrous methylene chloride (10 mL), and Dess-Martin periodinane (1.30 g, 3.06 mmol, 1.5 equiv) was added to the solution at 23 °C followed by water (55 mg, 3.06 mmol, 1.5 equiv). The white suspension was stirred for 30 min, and then an aqueous solution of 10% sodium thiosulfate/saturated sodium bicarbonate (1:1 v/v, 20 mL) was added. After stirring for another 10 min, the biphasic mixture was extracted with ethyl acetate (50 mL×3), and the organic phase was washed with saturated sodium bicarbonate (50 mL×2), dried over sodium sulfate, filtered, and concentrated to afford crude β-ketoester 10 as pale yellow oil. R f = 0. S1 To a 50 mL flask charged with the crude 10 obtained above and manganese(III) acetate dihydrate (1.37 g, 5.10 mmol, 2.5 equiv) was added acetic acid (15 mL) degassed by three freeze-pump-thaw cycles. The dark brown suspension was heated to 50 °C under argon for 8 h. Acetic acid was then removed and the residue was dissolved in ethyl acetate (50 mL) and a 10% aqueous sodium bisulfite solution (50 mL). The organic layer was separated and washed with brine (30 mL×2), dried over sodium sulfate, filtered, concentrated and purified with Biotage KP-C18-HS (39 x 157 mm, 120g) column (50%→65% acetonitrile/water). The impure fractions were collected and purified by preparative HPLC ( 0, 172.0, 156.2, 153.9, 151.5, 149.1, 137.5, 128.4, 127.8, 127.4, 124.7, 94.5, 81.3, 79.6, 73.3, 72.1, 70.0, 66.0, 60.8, 59.4, 45.0, 40.6, 38.0, 28.5, 28.4, 28.3, 24.6 3, 170.2, 155.8, 154.3, 153.7, 147.9, 137.3, 128.5, 128.1, 127.6, 124.0, 94.5, 81.5, 80.4, 73.2, 72.1, 68.7, 68.2, 59.6, 53.7, 46.3, 40.7, 40.6, 28.5, 28.3, 27.8, 24 
S2

S3
Alcohol 13. S1 To a solution of lactone 11 or 12 (0.324 g, 0.475 mmol, 1.0 equiv) in tetrahydrofuran (30 mL) was added a solution of lithium hydroxide (7.0 mL, 5.0 equiv, 0.34 N in water) at 23 °C. After stirring for 20 min, tetrahydrofuran was then removed by rotary evaporator and the residue was partitioned between ethyl acetate (50 mL) and brine (30 mL). The organic layer was further washed with saturated sodium bicarbonate (30 mL) and brine (30 mL), dried over 78.3.
: 788.2. sodium sulfate, filtered and concentrated to afford 13 as a colorless solid (279 mg, 90% crude yield), which was used directly for the next step without purification. R f = 0. S1 To a solution of crude alcohol 13 (279 mg, 0.426 mmol, 1.0 equiv) obtained above in anhydrous methylene chloride (3.0 mL) was added triethylamine (180 μL, 1.28 mmol, 3.0 equiv) followed by methanesulfonyl chloride (66 μL, 0.854 mmol, 2.0 equiv). After stirring at 23 °C for 30 min, the solvent was removed and the residue was dissolved in ethyl acetate (10 mL), washed with aqueous hydrogen chloride (8 mL, 0.1 N), saturated aqueous sodium bicarbonate (5 mL), brine (5 mL), dried over sodium sulfate, filtered and concentrated to afford the mesylate 13a as a colorless solid. This crude product was used directly for the next step without purification. Iodide 13b. The crude mesylate 13a obtained above was dissolved in acetone (12 mL) and sodium iodide (3.18 g, 21.2 mmol, 50 equiv) was added. After stirring at 70 °C for 2.5 h, the solvent was removed. The residue was suspended in chloroform (30 mL) and the solid was filtered off to remove most of the excess sodium iodide. After removing the solvent, the residue was dissolved in ethyl acetate (10 mL), washed with brine (5 mL×5), dried over sodium sulfate, filtered and concentrated to afford 13b as a white solid. This crude product was used directly for the next step without purification. Azide 14. The crude iodide 13b obtained above was dissolved in anhydrous dimethyl sulfoxide (2.0 mL), then sodium azide (138 mg, 2.12 mmol, 5 equiv) was added and the reaction was heated to 60 °C for 2 h. After the solvent was removed under high vacuum, the residue was dissolved in ethyl acetate (10 mL), washed with brine (5 mL×2 8, 156.4, 154.4, 151.9, 147.5, 137.4, 128.5, 128.0, 127.4, 124.0, 94.5, 81.3, 79.4, 73.1, 72.1, 65.7, 58.2, 49.5, 44.8, 41.1, 38.9, 37.3, 28.8, 28.6, 28.0, 24.8 
Triamine 15.
S2 To a 4 mL vial charged with azide 14 (117 mg, 0.172 mmol, 1.0 equiv) and triphenylphosphine (112 mg, 0.427 mmol, 2.5 equiv) was added tetrahydrofuran (2.0 mL) and water (0.50 mL). The reaction was heated to 70 °C overnight. The solvent was then removed by rotary evaporator and the residue was partitioned between ethyl acetate (10 mL) and brine (5 mL). The organic layer was separated, dried over sodium sulfate, filtered and concentrated. The residue was dissolved in methylene chloride (1 mL), and a methylene chloride solution of trifluoroacetic acid (2.0 mL, 20% v/v) was added. The reaction was stirred for 2 h before anhydrous toluene (1 mL) was added and the solvent was removed. The residue was then taken up in ethyl acetate (1 drop) and ether (3 mL) and sonicated to crush out 15 as a white solid. The solid was collected and washed with ether (10 mL) to afford crude 15 as a white powder (160 mg, 94% crude yield as calculated as a tris(trifluoroacetate) salt), which was used directly for the next step without purification. MS(ESI) 5, 162.78, 162.77, 162.0, 161.6, 139.8, 135.13, 135.11, 133.9, 133.8, 130.9, 130.7, 129.4, 128.6, 127.9, 127.6, 127.2, 127.0, 126.5, 123 .2 (two carbons), 122.3, 113.9 (two carbons), 97.7, 97.6, 74.4, 73.0, 60.6, 53.6, 47.1, 42.6, 39.0, 38.7, 37 Guanidine 16a. S1 To a 4 mL amber vial charged with amine 16 (126 mg, 0.114 mmol, 1.0 equiv), N,N'-di-Boc-1H-pyrazole-1-carboxamidine (106 mg, 0.342 mmol, 3.0 equiv) and 4-dimethylaminopyridine (2.8 mg, 0.023 mmol, 0.2 equiv) were added acetonitrile (1.0 mL) and triethylamine (95 μL, 0.68 mmol, 6.0 equiv), and then heated to 40 °C for 24 h. After the solvent was removed, the residue was purified by preparative HPLC (Waters Atlantis dC18 OBD, 19×150 mm, 5 μm, eluent A: water, eluent B: acetonitrile, gradient: T = 0 min: 60% B, T = 30 min: 100% B, 5.0 mL/min) to afford guanidine 16a as a white powder (84.1 mg, 60% yield, retention time: 30.1 min). R f = 0. (100 MHz, CDCl 3 , 40 °C) δ 184. 2, 163.2, 160.7, 160.6, 157.5, 156.1, 152.8, 152.4, 138.7, 132.8, 132.7, 129.0, 128.9, 128.3, 127.4, 127.1, 126.3, 126.0, 121.6, 121.2, 111.9, 111.8, 96.8, 96.7, 83.4, 79.5, 72.5, 70.7, 63.2, 52.3, 45.1, 40.8, 40.6, 39.3, 37.5, 28.3, 27.9 Aminoimidazole 17. To a 4 mL amber vial charged with guanidine 16a (27.7 mg, 0.0224 mmol, 1.0 equiv) and 2-iodoxybenzoic acid (18.8 mg, 0.0671 mmol, 3.0 equiv) was added anhydrous dimethyl sulfoxide (0.40 mL). The reaction was heated to 40 °C for 5 h before trifluoroacetic acid (0.86 μL, 0.011 mmol, 0.5 equiv) was added and the reaction was stirred for another 5 h at the same temperature. The reaction mixture was directly purified by preparative HPLC (Waters Atlantis dC18 OBD, 19×150 mm, 5 μm, eluent A: water with 0.1% trifluoroacetic acid, eluent B: methanol with 0.1% trifluoroacetic acid, gradient: T = 0 min: 70% B, T = 15 min: 85% B, 5.0 mL/min) without workup to afford 17 as a white powder (13.6 mg, 54% yield, retention time: 17.5 min). To crude 17a obtained above in tetrahydrofuran (0.40 mL) was added calcium borohydride bis(tetrahydrofuran) (11.0 mg, 0.0514 mmol, 5.0 equiv). The reaction was stirred at 23 °C for 3 h before the solvent was removed. This residue was then dissolved in acetic acid (0.40 mL) and sodium cyanoborohydride (3.5 mg, 0.056 mmol, 5.0 equiv) was added. After heating at 50 °C for 6 h, the solvent was removed and the residue was purified by preparative HPLC (Waters Atlantis dC18 OBD, 19×150 mm, 5 μm, eluent A: water with 0.1% trifluoroacetic acid, eluent B: methanol with 0.1% trifluoroacetic acid, gradient: T = 0 min: 60% B, T = 20 min: 80% B, 5.0 mL/min) to afford 18 as a white powder. (4.5 mg, 38% yield from 17 over three steps and as calculated as a mono(trifluoroacetate) salt, retention time: 24.2 min).
1 H NMR (400 MHz, CD 3 OD) δ 7.79-7.63 (m, 9H), 7.63-7.52 (m, 6H), 7.15-7.02 (m, 5H), 7.00 (d, J = 1.5 Hz, 1H), 6.99 (d, J = 1.5 Hz, 1H), 6.96 (d, J = 1.5 Hz, 1H), 6.85 (d, J = 1.5 Hz, 1H), 6.28 (s, 1H), 5.61 (d, J = 11.0 Hz, 1H), 5.41 (d, J = 11.0 Hz, 1H), 4.67 (d, J = 12.9 Hz, 1H), 4.61 (d, J = 12.9 Hz, 1H), 3.74 (dd, J = 14.6, 3.8 Hz, 1H), 3.61 (dd, J = 14.0, 2.6 Hz, 1H), 3.49 (d, J = 6.6 Hz, 1H), 3.44 (dd, J = 14.6, 4.5 Hz, 1H), 3.18 (dd, J = 13.6, 9.3 Hz, 1H), 2.90 (dd, J = 16.4, 4.0 Hz, 1H), 2.48 (ddd, J = 16.4, 7.2, 1.8 Hz, 1H), 2.18-2.03 (m, 1H), 2.03-1.92 (m, 1H); 13 C NMR (100 MHz, CD 3 OD) δ 163. 2, 163.0, 148.9, 148.1, 138.9, 134.9, 134.9, 133.7, 133.6, 130.7, 130.6, 129.5, 128.8, 128.2, 128.03, 127.98, 127.2, 127.1, 126.9, 124.6, 123.4, 123.2, 118.3, 114.5, 113.7, 112.0, 97.8, 97.7, 73.2, 72.4, 44.3, 42.7, 39.7, 37.0, 32.6, 23 
S7
Aminoimidazole 18a. S2 To a 4 mL amber vial charged with aminoimidazole 18 (3.2 mg, 0.0029 mmol, 1.0 equiv) was added methylene chloride (0.30 mL). The reaction was cooled to -40 °C before a methylene chloride solution of boron trichloride (87.5 μL, 0.0875 mmol, 30 equiv) was added. Then the reaction was warmed to -10 °C and stirred for 20 min. An acetonitrile solution of concentrated aqueous ammonium hydroxide (0.200 mL, 1:4 v/v) was then added and the reaction was stirred for another 30 min at 23 °C. After the solvent was removed, the residue was purified by HPLC (Eclipse XDB-C18, 9.4×250 mm, 5 μm, eluent A: water with 0.1% trifluoroacetic acid, eluent B: acetonitrile with 0.1% trifluoroacetic acid, gradient: T = 0 min: 30% B, T = 10 min: 50% B, 4.8 mL/min) to afford 18a as a white powder. (2.2 mg, 77% yield as calculated as a mono(trifluoroacetate) salt, retention time: 11.4 min). 162.9, 149.3, 149.2, 133.80, 133.77, 133.1, 133.0, 130.0, 129.9, 127.5, 127.2, 127.1, 123.3, 123.1, 122.8, 119.1, 114.2, 113.6, 113.0, 97.7, 97.6, 44.1, 42.8, 40.0, 37.2, 33.3, 23.7 
ent-Ageliferin (ent-1).
S2 To a 1.8 mL amber vial charged with aminoimidazole 18a (4.5 mg, 0.0045 mmol, 1.0 equiv) was added ethanol (50 μL) and aqueous HCl (50 μL, 0.20 N) . The reaction was heated at 60 °C for 6 h and purified directly by HPLC (Eclipse XDB-C18, 9.4×250 mm, 5 μm, eluent A: water with 0.1% trifluoroacetic acid, eluent B: acetonitrile with 0.1% trifluoroacetic acid, gradient: T = 0 min: 20% B, T = 8 min: 40% B, 4.8 mL/min) without workup to afford ent-1 as a white powder (3.4 mg, 88% yield as calculated as a bis(trifluoroacetate) salt, retention time: 8.5 min).
1 H NMR (600 MHz, CD 3 OD) δ 6.97 (dd, J = 1.5, 0.7 Hz, 1H), 6.94 (dd, J = 1.5, 0.7 Hz, 1H), 6.93 (dd, J = 1.5, 0.7 Hz, 1H), 6.83 (dd, J = 1.5, 0.7 Hz, 1H), 6.78 (s, 1H), 3.82 (d, J = 7.3 Hz, 1H), 3.78 (dd, J = 14.6, 4.2 Hz, 1H), 3.67 (dd, J = 14.0, 3.4 Hz, 1H), 3.50 (dd, J = 14.6, 4.9 Hz, 1H), 3.32 (dd, J = 14.0, 9.1 Hz, 1H), 2.77 (ddd, J = 16.4, 5.4, 1.2 Hz, 1H), 2.47 (ddd, J = 16.4, 8.0, 2.4 Hz, 1H), 2.28-2.23 (m, 1H), 2.15-2.11 (m, 1H); 13 C NMR (100 MHz, CD 3 OD) δ 163. 2, 162.9, 149.24, 149.18, 127.5, 127.2, 127.1, 123.3, 123.1, 122.8, 119.1, 114.2, 113.6, 113.0, 97.7, 97.6, 44.1, 42.8, 40.0, 37.2, 33.3, 23.7 
